PF-03715455
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-03715455, covering 2011-01-12 to 2019-06-12. Get the full timeline:
Most recent: Clinical Trial Update: An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma [Phase 2]